Strategic partnerships Leverage Sanfer's recent distribution collaboration with Hanmi Pharma to explore co-marketing, exclusive product launches, and regional expansion initiatives in Mexico and neighboring markets, focusing on GLP-1 therapies and chronic disease portfolios.

Expansion potential Target Sanfer's international footprint across Latin America and the strong presence in Mexico to propose localized product registrations, manufacturing partnerships, or contract development opportunities that align with their hospital, prescription, and over‑the‑counter portfolios.

Derm and specialty push Align sales efforts with Sanfer’s diversified portfolio across prescription, OTC, hospital solutions, and veterinary/genetic divisions to identify cross‑sell opportunities, especially in high‑demand therapeutic areas and animal health segments.

Investors and scale Capitalize on Sanfer’s notable funding history and growth trajectory, including CDPQ’s investment and the Vitalis acquisition, by presenting scalable product lines, digital health tools, and value‑driven partnerships that support accelerated market penetration.

Digital and data tools Engage with Sanfer’s tech stack and data capabilities (Power BI, Salesforce, Azure, CMS platforms) to offer analytics, CRM optimization, and digital marketing synergies that enhance product launches, performance tracking, and stakeholder engagement.